Vaxcyte, Inc. PCVX Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s operating income?
- Vaxcyte, Inc. (PCVX) reported operating income of -$345.85M in Q1 2026.
- How has Vaxcyte, Inc.'s operating income changed year-over-year?
- Vaxcyte, Inc.'s operating income decreased by 91.3% year-over-year, from -$180.79M to -$345.85M.
- What is the long-term trend for Vaxcyte, Inc.'s operating income?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s operating income has grown at a 72.8% compound annual growth rate (CAGR), from -$103.67M to -$923.68M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.